Cetera Investment Advisers
GMED icon

Cetera Investment Advisers’s Globus Medical GMED Stock Holding History

Cetera Investment Advisers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.09M Buy
51,719
+9,222
+22% +$784K ﹤0.01% 1772
2026
Q1 		$3.66M Buy
42,497
+4,464
+12% +$401K ﹤0.01% 1737
2025
Q4 		$3.32M Buy
38,033
+4,912
+15% +$373K ﹤0.01% 1771
2025
Q3 		$1.9M Buy
33,121
+26,683
+414% +$1.54M ﹤0.01% 2213
2025
Q2 		$380K Sell
6,438
-10,525
-62% -$680K ﹤0.01% 3185
2025
Q1 		$1.24M Buy
16,963
+8,700
+105% +$719K ﹤0.01% 2096
2024
Q4 		$683K Buy
8,263
+1,008
+14% +$79.5K ﹤0.01% 2441
2024
Q3 		$519K Buy
7,255
+2,431
+50% +$172K ﹤0.01% 2619
2024
Q2 		$330K Sell
4,824
-1,169
-20% -$69.8K ﹤0.01% 2939
2024
Q1 		$321K Buy
+5,993
New +$322K ﹤0.01% 2970
2023
Q1 		– Sell
-3,817
Closed -$283K – 2195
2022
Q4 		$283K Buy
+3,817
New +$260K ﹤0.01% 1702

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cetera Investment Advisers's GMED Position: Q2 2026 in Review

Cetera Investment Advisers increased its Globus Medical (GMED) stake by 22% in Q2 2026, buying an estimated $784K and bringing the position to 51,719 shares worth $4.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1772.

Cetera Investment Advisers first reported a position in GMED in Q4 2022 and has held it in 11 quarters since. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cetera Investment Advisers held 51,719 shares of Globus Medical worth $4.09M as of Q2 2026.
  • Cetera Investment Advisers bought 9,222 Globus Medical shares in Q2 2026, an estimated $784K.
  • Globus Medical made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1772 holding.
  • Cetera Investment Advisers first reported a position in Globus Medical in Q4 2022 and has held it in 11 quarters since.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.